UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles

Philosophical transactions of the Royal Society of London. Series A: Mathematical, physical, and engineering sciences, 2010-03, Vol.368 (1915), p.1333-1383

2010

Volltextzugriff (PDF)

Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD

Neurology, 2005-08, Vol.65 (3), p.404

2005

Volltextzugriff (PDF)

Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline

Neurology, 2010-06, Vol.74 (24), p.1969

2010

Volltextzugriff (PDF)

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

Molecular psychiatry, 2014-09, Vol.19 (9), p.1044-1051

2014

Volltextzugriff (PDF)

Explaining the encoding/retrieval flip: Memory-related deactivations and activations in the posteromedial cortex

Neuropsychologia, 2012-12, Vol.50 (14), p.3764-3774

2012

Volltextzugriff (PDF)

fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease

Journal of neurology, neurosurgery and psychiatry, 2003-01, Vol.74 (1), p.44-50

2003

Volltextzugriff (PDF)

What goes down must come up: role of the posteromedial cortices in encoding and retrieval

Cerebral cortex (New York, N.Y. 1991), 2011-01, Vol.21 (1), p.22-34

2011

Volltextzugriff (PDF)

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis

Multiple sclerosis, 2007-09, Vol.13 (8), p.1004-1010

2007

Volltextzugriff (PDF)

Editorial: Are We There Yet (and How Do We Get There…)?

The journal of prevention of Alzheimer's disease, 2023-01, Vol.10, p.S1-S2

Sperling, R A

2023

Volltextzugriff (PDF)

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults

Neurology, 2011-04, Vol.76 (16), p.1395

2011

Volltextzugriff (PDF)

Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease

Neurology, 2007-09, Vol.69 (13), p.1331

2007

Volltextzugriff (PDF)

Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline

Journal of neurology, neurosurgery and psychiatry, 2008-06, Vol.79 (6), p.630-635

2008

Volltextzugriff (PDF)

Electrophoretic Separation of Nanoparticles with a Discrete Number of Functional Groups

Advanced functional materials, 2006-05, Vol.16 (7), p.943-948

2006

Volltextzugriff (PDF)

Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers

Journal of neurology, neurosurgery and psychiatry, 2013-05, Vol.84 (5), p.556-561

2013

Volltextzugriff (PDF)

Size Determination of (Bio)conjugated Water-Soluble Colloidal Nanoparticles: A Comparison of Different Techniques

Journal of physical chemistry. C, 2007-08, Vol.111 (31), p.11552-11559

2007

Volltextzugriff (PDF)

Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials

The journal of prevention of Alzheimer's disease, 2020, Vol.7 (4), p.213-218

2020

Volltextzugriff (PDF)

Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aβ Status Groups in the A4 Study

The journal of prevention of Alzheimer's disease, 2024-01, Vol.11 (1), p.48-55

2024

Volltextzugriff (PDF)

Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial

The journal of prevention of Alzheimer's disease, 2024, Vol.11 (4), p.857-868

2024

Volltextzugriff (PDF)

Longitudinal Trajectories of the Cognitive Function Index in the A4 Study

The journal of prevention of Alzheimer's disease, 2024, Vol.11 (4), p.838-845

2024

Volltextzugriff (PDF)

Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study

The journal of prevention of Alzheimer's disease, 2024, Vol.11 (4), p.814-822

2024

Volltextzugriff (PDF)

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview

The journal of prevention of Alzheimer's disease, 2020, Vol.7 (4), p.208-212

2020

Volltextzugriff (PDF)

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer’s Disease: Secondary Analyses from the A4 Study

The journal of prevention of Alzheimer's disease, 2024, Vol.11 (4), p.846-856

2024

Volltextzugriff (PDF)

Maximizing the Utility of Alzheimer’s Disease Trial Data: Sharing of Baseline A4 and LEARN Data

The journal of prevention of Alzheimer's disease, 2024, Vol.11 (4), p.889-894

2024

Volltextzugriff (PDF)

Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer’s Disease: A Comprehensive Review of the Colombian Kindred

The journal of prevention of Alzheimer's disease, 2019, Vol.6 (2), p.112-120

2019

Volltextzugriff (PDF)

Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data

The journal of prevention of Alzheimer's disease, 2021, Vol.8 (3), p.257-262

2021

Volltextzugriff (PDF)

1 – 25 von 2.727

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.458)
Mit Volltextzugriff
(2.171)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.559)
Ovid Journals
(1.346)
IngentaConnect
(1.161)
EZB Electronic Journals Library
(1.085)
NUS Single-Journal Subscriptions
(711)
Access via ScienceDirect (Elsevier)
(691)
Wiley-Blackwell Journals
(662)
IngentaConnect Journals
(595)
Wiley Online Library
(387)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(366)
SpringerLink (Online service)
(233)
Oxford journals
(139)
JSTOR
(121)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(117)
Oxford Journals 2020 Medicine
(105)
Nature Journals
(90)
Nexis Uni
(52)
HEAL-Link subscriptions: Springer Book Series
(47)
SAGE Publications
(46)
Ebook Central Perpetual and DDA
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(27)

Menü

Weitere Dienste

Einstellungen

Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles

Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD

Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

Explaining the encoding/retrieval flip: Memory-related deactivations and activations in the posteromedial cortex

fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease

What goes down must come up: role of the posteromedial cortices in encoding and retrieval

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis

Editorial: Are We There Yet (and How Do We Get There…)?

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults

Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease

Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline

Electrophoretic Separation of Nanoparticles with a Discrete Number of Functional Groups

Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers

Size Determination of (Bio)conjugated Water-Soluble Colloidal Nanoparticles: A Comparison of Different Techniques

Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials

Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aβ Status Groups in the A4 Study

Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial

Longitudinal Trajectories of the Cognitive Function Index in the A4 Study

Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer’s Disease: Secondary Analyses from the A4 Study

Maximizing the Utility of Alzheimer’s Disease Trial Data: Sharing of Baseline A4 and LEARN Data

Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer’s Disease: A Comprehensive Review of the Colombian Kindred

Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data

Suchergebnisse filtern